Experts from Ballinger, Children’s Hospital of Philadelphia and IPS gave a presentation at the ISPE 2020 Facilities of the Future Conference. Their talk “Manufacturing Cell and Gene Therapies within the Academic Medical Center Environment” explored the road to a fully validated drug development facility and how architecture and engineering can support the translational research continuum from bench to bedside.
Ballinger Principal Dennis Potter, PE, LEED AP joined Johannes van der Loo, PhD of Children’s Hospital of Philadelphia (CHOP) and Anthony Relvas of IPS to share a case study of a new 15,000 SF cGMP facility on CHOP’s West Philadelphia campus. The presentation covered early planning stages through design, construction, commissioning and qualification, with a focus on how a fully integrated team developed a space that is helping to realize the enormous promise of gene transfer therapy to address unmet medical needs.
The mission of the International Society for Pharmaceutical Engineering (ISPE) is to connect pharmaceutical knowledge to deliver manufacturing and supply chain innovation, operational excellence and regulatory insights. Their annual Facilities of the Future Conference, held this year in San Francisco, brings together professionals involved in all facets of the pharmaceutical manufacturing lifecycle.